Budoff MJ, Rader DJ, Reilly MP, Mohler ER III, Lash J, Yang W, Rosen L, Glenn M, Teal V, Feldman HI, CRIC Study Investigators (2011) Relationship of estimated GFR and coronary artery calcification in the CRIC (chronic renal insufficiency cohort) study. Am J Kidney Dis 58(4):519–526

Article  PubMed  PubMed Central  Google Scholar 

Lee SJ, Lee I-K, Jeon J-H (2020) Vascular calcification—new insights into its mechanism. Int J Mol Sci 21:2685

Article  PubMed  PubMed Central  CAS  Google Scholar 

Benz K, Varga I, Neureiter D, Campean V, Daniel C, Heim C, Reimann A, Weyand M, Hilgers KF, Amann K (2017) Vascular inflammation and media calcification are already present in early stages of chronic kidney disease. Cardiovasc Pathol 27:57–67

Article  PubMed  Google Scholar 

Okyay GU, Er RE, Tekbudak MY, Paşaoğlu Ö, Inal S, Öneç K, Paşaoğlu H, Altok K, Derici Ü, Erten Y (2013) Novel inflammatory marker in dialysis patients. Ther Apher Dial 17(2):193–201

Article  PubMed  CAS  Google Scholar 

Nielsen TL, Plesner LL, Warming PE, Pallisgaard JL, Dalsgaard M, Schou M, Høst U, Rydahl C, Brandi L, Køber L, Johansen JS, Kastrup J, Iversen KK (2018) YKL-40 in patients with end-stage renal disease receiving haemodialysis. Biomarkers 23(4):357–363

Article  PubMed  CAS  Google Scholar 

Vega A, Sanchez-Niño MD, Ortiz A, Abad S, Macías N, Aragoncillo I, Sants A, García-Prieto A, Torres E, Hernández A, Sánchez-Cámara L, Hurtado E, Valiño-Rivas L, Luño J (2019) The new marker YKL-40, a molecule related to inflammation, is associated with cardiovascular events in stable haemodialysis pa -tients. Clin Kidney J 13(2):172–178

Article  PubMed  PubMed Central  Google Scholar 

Bi SH, Su C, Yang P, Zhang X, Wang Y, Tang W, Yang W, He L (2023) Higher serum trimethylamine N-oxide (TMAO) levels are associated with increased visceral fat in hemodialysis patients. Clin Nephrol 100(6):275–283

Article  PubMed  CAS  Google Scholar 

Kauppila LI, Polak JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW (1997) New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 132(2):245–250

Article  PubMed  CAS  Google Scholar 

Peeters MJ, van den Brand JA, van Zuilen AD, Koster Y, Bots ML, Vervloet MG, Blankestijn PJ, Wetzels JF, MASTERPLAN Study Group (2017) Abdominal aortic calcification in patients with CKD. J Nephrol 30(1):109–118

Article  PubMed  CAS  Google Scholar 

Zhou SJ, Wang XX, Shi JB, Han QF, He L, Tang W, Zhang AH (2021) Serum fatty acid binding protein 4 levels are associated with abdominal aortic calcification in peritoneal dialysis patients. Ren Fail 43(1):1539–1548

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lorenz G, Schmalenberg M, Kemmner S, Haller B, Steubl D, Pham D, Schreiegg A, Bachmann Q, Schmidt A, Haderer S, Huber M, Angermann S, Günt-hner R, Braunisch M, Hauser C, Reichelt AL, Matschkal J, Suttmann Y, Moo-g P, Stock K, Küchle C, Thürmel K, Renders L, Bauer A, Baumann M, He-emann U, Luppa PB, Schmaderer C (2018) Mortality prediction in stable hemodialysis patients is refined by YKL-40, a 40 kDa glycoprotein associated with inflammation. Kidney Int 93:221–230

Article  PubMed  CAS  Google Scholar 

Bojesen SE, Johansen JS, Nordestgaard BG (2011) Plasma YKL-40 levels in healthy subjects from the general population. Clin Chim Acta 412(9–10):709–712

Article  PubMed  CAS  Google Scholar 

Pawlak K, Rozkiewicz D, Mysliwiec M, Pawlak D (2013) YKL-40 in hemodialyzed patients with and without cardiovascular complications–the enhancement by the coexistence of the seropositivity against hepatitis C virus infection. Cytokine 62:75–80

Article  PubMed  CAS  Google Scholar 

Nielsen AR, Plomgaard P, Krabbe KS, Johansen JS, Pedersen BK (2011) IL-6, but not TNF-a, increases plasma YKL-40 in human subjects. Cytokine 55:152–155

Article  PubMed  CAS  Google Scholar 

Vind I, Johansen JS, Price PA, Munkholm P (2003) SerumYKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease. Scand J Gastroenterol 38:599–605

Article  PubMed  CAS  Google Scholar 

Arain F, Abraityte A, Bogdanova M, Solberg OG, Michelsen AE, Lekva T, Aakhus S, Holm S, Halvorsen B, Finsen AV, Vinge LE, Nymo S, Espeland T, Ranheim T, Aukrust P, Vaage IJ, Auensen A, Gullestad L, Ueland T (2020) YKL-40 (chitinase-3-Like Protein 1) serum levels in aortic stenosis. Circ Heart Fail 13(10):e006643

Article  PubMed  CAS  Google Scholar 

Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T, Krohg-Sørensen K, Klingvall MF, Brosstad F, Oie E, Vestergaard H, Aukrust P, Halvorsen B (2010) Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis 211:589–595

Article  PubMed  CAS  Google Scholar 

Bossé Y, Miqdad A, Fournier D, Pépin A, Pibarot P, Mathieu P (2009) Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal and calcified stenotic human aortic valves. Circ Cardiovasc Genet 2:489–498

Article  PubMed  Google Scholar 

Persson F, Borg R (2018) YKL-40 in dialysis patients: another candidate in the quest for useful biomarkers in nephrology. Kidney Int 93:21–22

Article  PubMed  CAS  Google Scholar 

Volck B, Price PA, Johansen JS (1998) YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians 110:351–360

PubMed  CAS  Google Scholar 

Ma WH, Wang XL, Du YM, Wang YB, Zhang Y, Wei DE, Guo LL, Bu PL (2012) Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension. BMC Cardiovasc Disord 12:35

Article  PubMed  PubMed Central  CAS  Google Scholar 

Johansen JS (2006) Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 53(2):172–209

PubMed  CAS  Google Scholar 

Prakash M, Bodas M, Prakash D, Nawani N, Khetmalas M, Mandal A, Eriksson C (2013) Diverse pathological implications of YKL-40: answers may lie in “outside-in” signaling. Cell Signal 25:1567–1573

Article  PubMed  CAS  Google Scholar 

Disthabanchong S (2012) Vascular calcification in chronic kidney disease: pathogenesis and clinical implication. World J Nephrol 1(2):43–53

Article  PubMed  PubMed Central  Google Scholar 

Rathcke CN, Vestergaard H (2006) YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res 55:221–227

Article  PubMed  CAS  Google Scholar 

Rathcke CN, Persson F, Tarnow L, Rossing P, Vestergaard H (2009) YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria. Diabetes Care 32:323–328

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kyrgios I, Galli-Tsinopoulou A, Stylianou C, Papakonstantinou E, Arvanitidou M, Haidich AB (2012) Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children. Metabolism 61:562–568

Article  PubMed  CAS  Google Scholar 

Żurawska-Płaksej E, Ługowska A, Hetmańczyk K, Knapik-Kordecka M, Piwowar A (2015) Neutrophils as a source of chitinases and chitinase-like proteins in type 2 diabetes. PLoS ONE 10:e0141730

Article  PubMed  PubMed Central  Google Scholar 

Kapoula GV, Kontou PI, Bagos PG (2020) Diagnostic performance of biomarkers urinary KIM-1 and YKL-40 for early diabetic nephropathy, in patients with type 2 diabetes: a systematic review and meta-analysis. Diagnostics (Basel) 10(11):909

Article